Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 4.49098855 |
2 | central nervous system myelination (GO:0022010) | 4.49098855 |
3 | regulation of fever generation (GO:0031620) | 4.26835675 |
4 | membrane budding (GO:0006900) | 4.22782073 |
5 | Golgi transport vesicle coating (GO:0048200) | 3.91931001 |
6 | COPI coating of Golgi vesicle (GO:0048205) | 3.91931001 |
7 | fatty acid elongation (GO:0030497) | 3.89242073 |
8 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.74005984 |
9 | neuronal action potential propagation (GO:0019227) | 3.59992101 |
10 | protein localization to endosome (GO:0036010) | 3.59299713 |
11 | COPII vesicle coating (GO:0048208) | 3.50504914 |
12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47622318 |
13 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.39596170 |
14 | cullin deneddylation (GO:0010388) | 3.38743548 |
15 | cell adhesion mediated by integrin (GO:0033627) | 3.36579587 |
16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.28480498 |
17 | ensheathment of neurons (GO:0007272) | 3.25738111 |
18 | axon ensheathment (GO:0008366) | 3.25738111 |
19 | proteasome assembly (GO:0043248) | 3.25598163 |
20 | synaptic vesicle maturation (GO:0016188) | 3.25099949 |
21 | myelination (GO:0042552) | 3.24481139 |
22 | negative regulation of neurotransmitter transport (GO:0051589) | 3.23577114 |
23 | protein deneddylation (GO:0000338) | 3.23249402 |
24 | cellular potassium ion homeostasis (GO:0030007) | 3.18344454 |
25 | cellular response to leptin stimulus (GO:0044320) | 3.16675691 |
26 | vesicle coating (GO:0006901) | 3.15449950 |
27 | synaptic vesicle exocytosis (GO:0016079) | 3.15042446 |
28 | linoleic acid metabolic process (GO:0043651) | 3.14911242 |
29 | skin morphogenesis (GO:0043589) | 3.07891023 |
30 | * regulation of synaptic vesicle exocytosis (GO:2000300) | 3.04220205 |
31 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.04032183 |
32 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.02035664 |
33 | positive regulation of heat generation (GO:0031652) | 3.01474727 |
34 | glutamate secretion (GO:0014047) | 3.01047754 |
35 | mating behavior (GO:0007617) | 2.99015081 |
36 | regulation of podosome assembly (GO:0071801) | 2.96446401 |
37 | clathrin coat assembly (GO:0048268) | 2.94884728 |
38 | Rap protein signal transduction (GO:0032486) | 2.93678455 |
39 | L-amino acid import (GO:0043092) | 2.92416967 |
40 | cellular protein complex localization (GO:0034629) | 2.92388360 |
41 | neuromuscular process controlling posture (GO:0050884) | 2.91552154 |
42 | positive regulation of protein autophosphorylation (GO:0031954) | 2.88757281 |
43 | myelin maintenance (GO:0043217) | 2.88542693 |
44 | regulation of heat generation (GO:0031650) | 2.87247861 |
45 | membrane invagination (GO:0010324) | 2.86946420 |
46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.84134877 |
47 | positive regulation of actin filament depolymerization (GO:0030836) | 2.82968766 |
48 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.81706351 |
49 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.81365702 |
50 | cerebellar granule cell differentiation (GO:0021707) | 2.81281078 |
51 | negative regulation of inclusion body assembly (GO:0090084) | 2.81075550 |
52 | nerve growth factor signaling pathway (GO:0038180) | 2.78980294 |
53 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.77077153 |
54 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.77006798 |
55 | sodium ion export (GO:0071436) | 2.76601054 |
56 | locomotory exploration behavior (GO:0035641) | 2.75393161 |
57 | asymmetric protein localization (GO:0008105) | 2.75262999 |
58 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74961811 |
59 | positive regulation of macroautophagy (GO:0016239) | 2.73308309 |
60 | establishment of mitochondrion localization (GO:0051654) | 2.72456078 |
61 | ganglion development (GO:0061548) | 2.72337565 |
62 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.70259431 |
63 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.70193062 |
64 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70098761 |
65 | response to leptin (GO:0044321) | 2.69669405 |
66 | vesicle transport along microtubule (GO:0047496) | 2.69219280 |
67 | organelle transport along microtubule (GO:0072384) | 2.66753542 |
68 | apical protein localization (GO:0045176) | 2.66742927 |
69 | thioester biosynthetic process (GO:0035384) | 2.66595530 |
70 | acyl-CoA biosynthetic process (GO:0071616) | 2.66595530 |
71 | magnesium ion transport (GO:0015693) | 2.65112112 |
72 | establishment of integrated proviral latency (GO:0075713) | 2.64877803 |
73 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.64770645 |
74 | Golgi to plasma membrane protein transport (GO:0043001) | 2.64187317 |
75 | regulation of collateral sprouting (GO:0048670) | 2.64127631 |
76 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.62317199 |
77 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.62275972 |
78 | peptidyl-cysteine modification (GO:0018198) | 2.59580451 |
79 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.59136500 |
80 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.57649969 |
81 | sterol biosynthetic process (GO:0016126) | 2.56413863 |
82 | gamma-aminobutyric acid transport (GO:0015812) | 2.56357737 |
83 | transmission of nerve impulse (GO:0019226) | 2.55070059 |
84 | regulation of mononuclear cell migration (GO:0071675) | 2.54102634 |
85 | response to methylmercury (GO:0051597) | 2.53395367 |
86 | establishment of viral latency (GO:0019043) | 2.53237094 |
87 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.52905164 |
88 | * regulation of synaptic vesicle transport (GO:1902803) | 2.51810004 |
89 | layer formation in cerebral cortex (GO:0021819) | 2.51265493 |
90 | macroautophagy (GO:0016236) | 2.50965198 |
91 | creatine metabolic process (GO:0006600) | 2.49369295 |
92 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.48871134 |
93 | neuron cell-cell adhesion (GO:0007158) | 2.48749310 |
94 | dendritic spine morphogenesis (GO:0060997) | 2.48016121 |
95 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.47847836 |
96 | establishment of melanosome localization (GO:0032401) | 2.47831349 |
97 | phagocytosis, engulfment (GO:0006911) | 2.46878048 |
98 | response to lipoprotein particle (GO:0055094) | 2.45715354 |
99 | acidic amino acid transport (GO:0015800) | 2.45411443 |
100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43880992 |
101 | positive regulation of autophagy (GO:0010508) | 2.43437947 |
102 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.43311397 |
103 | neuron remodeling (GO:0016322) | 2.42489092 |
104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.42352668 |
105 | L-phenylalanine catabolic process (GO:0006559) | 2.42352668 |
106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.42248239 |
107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.41375587 |
108 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.41299153 |
109 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.41092246 |
110 | establishment of pigment granule localization (GO:0051905) | 2.40853226 |
111 | amino acid import (GO:0043090) | 2.40152521 |
112 | glucosamine-containing compound catabolic process (GO:1901072) | 2.38998019 |
113 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.38718255 |
114 | neuromuscular process controlling balance (GO:0050885) | 2.38054446 |
115 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.37369679 |
116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.37144240 |
117 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.36105918 |
118 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.35740215 |
119 | L-glutamate transport (GO:0015813) | 2.35307653 |
120 | sequestering of metal ion (GO:0051238) | 2.35149510 |
121 | melanosome transport (GO:0032402) | 2.34603633 |
122 | cellular copper ion homeostasis (GO:0006878) | 2.33118432 |
123 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.32689545 |
124 | neurotransmitter secretion (GO:0007269) | 2.32544113 |
125 | potassium ion homeostasis (GO:0055075) | 2.32039491 |
126 | neuron recognition (GO:0008038) | 2.31643723 |
127 | endoplasmic reticulum organization (GO:0007029) | 2.31357952 |
128 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.30987956 |
129 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.30704053 |
130 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.29993573 |
131 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.29222592 |
132 | neurotransmitter catabolic process (GO:0042135) | 2.28909773 |
133 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.28107351 |
134 | pigment granule transport (GO:0051904) | 2.27909582 |
135 | localization within membrane (GO:0051668) | 2.27584821 |
136 | potassium ion import (GO:0010107) | 2.27389697 |
137 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.27387568 |
138 | transcytosis (GO:0045056) | 2.26863888 |
139 | regulation of Rac protein signal transduction (GO:0035020) | 2.26522352 |
140 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.25544534 |
141 | regulation of early endosome to late endosome transport (GO:2000641) | 2.25499436 |
142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25239319 |
143 | ribosome assembly (GO:0042255) | 2.25214359 |
144 | negative regulation of DNA recombination (GO:0045910) | 2.24409478 |
145 | ER overload response (GO:0006983) | 2.24346754 |
146 | protein maturation by protein folding (GO:0022417) | 2.23836532 |
147 | long term synaptic depression (GO:0060292) | 2.23668413 |
148 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.23492556 |
149 | labyrinthine layer development (GO:0060711) | 2.22982660 |
150 | cholesterol biosynthetic process (GO:0006695) | 2.22567564 |
151 | cysteine metabolic process (GO:0006534) | 2.21562361 |
152 | eosinophil chemotaxis (GO:0048245) | 2.21348070 |
153 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.21188347 |
154 | very long-chain fatty acid metabolic process (GO:0000038) | 2.21001978 |
155 | protein complex localization (GO:0031503) | 2.20551964 |
156 | L-phenylalanine metabolic process (GO:0006558) | 2.19821756 |
157 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.19821756 |
158 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.19692742 |
159 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18928787 |
160 | response to nerve growth factor (GO:1990089) | 2.17826213 |
161 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.17826213 |
162 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.17799106 |
163 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.17757551 |
164 | glycerophospholipid catabolic process (GO:0046475) | 2.17272070 |
165 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.16981161 |
166 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.16904497 |
167 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.16621498 |
168 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.16459646 |
169 | triglyceride biosynthetic process (GO:0019432) | 2.16431457 |
170 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.16339932 |
171 | presynaptic membrane assembly (GO:0097105) | 2.14994037 |
172 | positive regulation of interleukin-6 production (GO:0032755) | 2.14714517 |
173 | lung-associated mesenchyme development (GO:0060484) | 2.14559301 |
174 | activation of protein kinase A activity (GO:0034199) | 2.14500025 |
175 | positive regulation of vesicle fusion (GO:0031340) | 2.14457033 |
176 | regulation of vesicle fusion (GO:0031338) | 2.14241667 |
177 | dendrite morphogenesis (GO:0048813) | 2.14083724 |
178 | intestinal epithelial cell development (GO:0060576) | 2.13250422 |
179 | neutral lipid biosynthetic process (GO:0046460) | 2.13141828 |
180 | acylglycerol biosynthetic process (GO:0046463) | 2.13141828 |
181 | protein targeting to Golgi (GO:0000042) | 2.12440541 |
182 | autophagic vacuole assembly (GO:0000045) | 2.12145741 |
183 | positive regulation of potassium ion transport (GO:0043268) | 2.11971346 |
184 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.11321242 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.03518613 |
2 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.83214713 |
3 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.47171442 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45321304 |
5 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.43512827 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.32167876 |
7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25501609 |
8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.16908132 |
9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16409454 |
10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.13725863 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03521206 |
12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.00209074 |
13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99912000 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98277951 |
15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.96913992 |
16 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.93063543 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86677027 |
18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.84394314 |
19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82769674 |
20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81502268 |
21 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76258356 |
22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.75452831 |
23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75350259 |
24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75333803 |
25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74310531 |
26 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.72064547 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70165636 |
28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.67015802 |
29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64774693 |
30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64101653 |
31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64101653 |
32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63482263 |
33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61976606 |
34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60912127 |
35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60912127 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60363181 |
37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60203121 |
38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59339005 |
39 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.59325718 |
40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58628420 |
41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58437212 |
42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56276056 |
43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56167371 |
44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54422833 |
45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53231766 |
46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51376665 |
47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.50402516 |
48 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.48590748 |
49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48514714 |
50 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.47532632 |
51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47480500 |
52 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.46717321 |
53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45783554 |
54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44974027 |
55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44880842 |
56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44058241 |
57 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.43047607 |
58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.41065406 |
59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39518292 |
60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36465394 |
61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35565523 |
62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34696713 |
63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33597844 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33119348 |
65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32884891 |
66 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.32707796 |
67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32264910 |
68 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.31634147 |
69 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31092930 |
70 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.29103174 |
71 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29002781 |
72 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27719041 |
73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27644205 |
74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27442904 |
75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.27357578 |
76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26495872 |
77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.25400056 |
78 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25383006 |
79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25236480 |
80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25236480 |
81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25208576 |
82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.25128754 |
83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24189064 |
84 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.23497486 |
85 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.22821820 |
86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22213555 |
87 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21954429 |
88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21227603 |
89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21047088 |
90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.20450049 |
91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20032239 |
92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19717023 |
93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19705331 |
94 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19203308 |
95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18842899 |
96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17813021 |
97 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17462806 |
98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.17462789 |
99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16670329 |
100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16416091 |
101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16406807 |
102 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14675366 |
103 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14065385 |
104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13509321 |
105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12552717 |
106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11121575 |
107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10901751 |
108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10544761 |
109 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10514031 |
110 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10082094 |
111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08631089 |
112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08135493 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07991331 |
114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07962950 |
115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07792750 |
116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07698625 |
117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07078567 |
118 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06574842 |
119 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06089603 |
120 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06004604 |
121 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.04905414 |
122 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04761410 |
123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02736618 |
124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02404103 |
125 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02148017 |
126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02126666 |
127 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01230878 |
128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01092336 |
129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00412757 |
130 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00250182 |
131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99813419 |
132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99521150 |
133 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98799452 |
134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98547126 |
135 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98478452 |
136 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.98197135 |
137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98038629 |
138 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97761763 |
139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97474346 |
140 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97297020 |
141 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96808020 |
142 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96017836 |
143 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96014194 |
144 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95727084 |
145 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95686326 |
146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95652059 |
147 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94774984 |
148 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94210801 |
149 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94021617 |
150 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93763723 |
151 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93558939 |
152 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92190745 |
153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92122615 |
154 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91742204 |
155 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91587266 |
156 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89651007 |
157 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87074464 |
158 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87074464 |
159 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87074464 |
160 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86878874 |
161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86635089 |
162 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86390727 |
163 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85878932 |
164 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85824330 |
165 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85806567 |
166 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85039971 |
167 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84904797 |
168 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84884350 |
169 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84651486 |
170 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84611283 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010352_gastrointestinal_tract_polyps | 4.40140786 |
2 | MP0006054_spinal_hemorrhage | 3.95594200 |
3 | MP0003329_amyloid_beta_deposits | 3.57663944 |
4 | MP0004270_analgesia | 3.36521170 |
5 | MP0004859_abnormal_synaptic_plasticity | 3.32770399 |
6 | MP0010234_abnormal_vibrissa_follicle | 3.31867389 |
7 | MP0003941_abnormal_skin_development | 3.27077683 |
8 | MP0003880_abnormal_central_pattern | 3.14172759 |
9 | MP0000920_abnormal_myelination | 2.59015617 |
10 | MP0003303_peritoneal_inflammation | 2.58440462 |
11 | MP0000013_abnormal_adipose_tissue | 2.48105836 |
12 | MP0003635_abnormal_synaptic_transmissio | 2.40473114 |
13 | MP0003690_abnormal_glial_cell | 2.36136661 |
14 | MP0002332_abnormal_exercise_endurance | 2.29649930 |
15 | MP0000604_amyloidosis | 2.28466108 |
16 | MP0003221_abnormal_cardiomyocyte_apopto | 2.26574554 |
17 | MP0002064_seizures | 2.15195350 |
18 | MP0004885_abnormal_endolymph | 2.13224462 |
19 | MP0001188_hyperpigmentation | 2.10540618 |
20 | MP0001440_abnormal_grooming_behavior | 2.03290891 |
21 | MP0002909_abnormal_adrenal_gland | 1.98809393 |
22 | MP0000343_altered_response_to | 1.93850484 |
23 | MP0003300_gastrointestinal_ulcer | 1.93367300 |
24 | MP0004043_abnormal_pH_regulation | 1.92943661 |
25 | MP0001529_abnormal_vocalization | 1.90526922 |
26 | MP0009046_muscle_twitch | 1.89794832 |
27 | MP0003566_abnormal_cell_adhesion | 1.89735985 |
28 | MP0001501_abnormal_sleep_pattern | 1.87096920 |
29 | MP0002272_abnormal_nervous_system | 1.85890171 |
30 | MP0002796_impaired_skin_barrier | 1.81417266 |
31 | MP0004858_abnormal_nervous_system | 1.80035396 |
32 | MP0002063_abnormal_learning/memory/cond | 1.79455934 |
33 | MP0009840_abnormal_foam_cell | 1.78265685 |
34 | MP0004185_abnormal_adipocyte_glucose | 1.75622645 |
35 | MP0003195_calcinosis | 1.75588023 |
36 | MP0004510_myositis | 1.75484522 |
37 | MP0002734_abnormal_mechanical_nocicepti | 1.74383284 |
38 | MP0003634_abnormal_glial_cell | 1.73553014 |
39 | MP0009745_abnormal_behavioral_response | 1.70143874 |
40 | MP0009780_abnormal_chondrocyte_physiolo | 1.69600450 |
41 | MP0005248_abnormal_Harderian_gland | 1.68313425 |
42 | MP0002733_abnormal_thermal_nociception | 1.63177801 |
43 | MP0000747_muscle_weakness | 1.62759046 |
44 | MP0001984_abnormal_olfaction | 1.61035222 |
45 | MP0010678_abnormal_skin_adnexa | 1.55158414 |
46 | MP0003448_altered_tumor_morphology | 1.54315129 |
47 | MP0005367_renal/urinary_system_phenotyp | 1.53124223 |
48 | MP0000516_abnormal_urinary_system | 1.53124223 |
49 | MP0001486_abnormal_startle_reflex | 1.52946726 |
50 | MP0004272_abnormal_basement_membrane | 1.51473400 |
51 | MP0003724_increased_susceptibility_to | 1.51409857 |
52 | MP0002139_abnormal_hepatobiliary_system | 1.51053810 |
53 | MP0005085_abnormal_gallbladder_physiolo | 1.49401392 |
54 | MP0001542_abnormal_bone_strength | 1.49226456 |
55 | MP0005451_abnormal_body_composition | 1.47236347 |
56 | MP0003806_abnormal_nucleotide_metabolis | 1.44664776 |
57 | MP0003186_abnormal_redox_activity | 1.44494227 |
58 | MP0003075_altered_response_to | 1.44378095 |
59 | MP0003633_abnormal_nervous_system | 1.41812805 |
60 | MP0005501_abnormal_skin_physiology | 1.41807158 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.40880587 |
62 | MP0008004_abnormal_stomach_pH | 1.40052443 |
63 | MP0002572_abnormal_emotion/affect_behav | 1.38343179 |
64 | MP0001299_abnormal_eye_distance/ | 1.37462939 |
65 | MP0003705_abnormal_hypodermis_morpholog | 1.37036486 |
66 | MP0001915_intracranial_hemorrhage | 1.36852940 |
67 | MP0001970_abnormal_pain_threshold | 1.36761535 |
68 | MP0003091_abnormal_cell_migration | 1.35071853 |
69 | MP0005058_abnormal_lysosome_morphology | 1.33547045 |
70 | MP0001853_heart_inflammation | 1.30792206 |
71 | MP0001727_abnormal_embryo_implantation | 1.28341147 |
72 | MP0005165_increased_susceptibility_to | 1.27207556 |
73 | MP0009384_cardiac_valve_regurgitation | 1.24942819 |
74 | MP0008260_abnormal_autophagy | 1.23266514 |
75 | MP0005623_abnormal_meninges_morphology | 1.23048156 |
76 | MP0004742_abnormal_vestibular_system | 1.22876019 |
77 | MP0005257_abnormal_intraocular_pressure | 1.21549766 |
78 | MP0004924_abnormal_behavior | 1.20692366 |
79 | MP0005386_behavior/neurological_phenoty | 1.20692366 |
80 | MP0000778_abnormal_nervous_system | 1.19384469 |
81 | MP0003631_nervous_system_phenotype | 1.18991590 |
82 | MP0009764_decreased_sensitivity_to | 1.17875175 |
83 | MP0005535_abnormal_body_temperature | 1.15660185 |
84 | MP0006082_CNS_inflammation | 1.15119822 |
85 | MP0005360_urolithiasis | 1.15070827 |
86 | MP0000955_abnormal_spinal_cord | 1.14190358 |
87 | MP0005166_decreased_susceptibility_to | 1.12954899 |
88 | MP0003632_abnormal_nervous_system | 1.10614867 |
89 | MP0002067_abnormal_sensory_capabilities | 1.10338954 |
90 | MP0002066_abnormal_motor_capabilities/c | 1.09612562 |
91 | MP0001666_abnormal_nutrient_absorption | 1.09237902 |
92 | MP0005332_abnormal_amino_acid | 1.08116451 |
93 | MP0002254_reproductive_system_inflammat | 1.08052861 |
94 | MP0002118_abnormal_lipid_homeostasis | 1.07017585 |
95 | MP0002837_dystrophic_cardiac_calcinosis | 1.06865108 |
96 | MP0001485_abnormal_pinna_reflex | 1.06505913 |
97 | MP0004130_abnormal_muscle_cell | 1.06477144 |
98 | MP0000358_abnormal_cell_content/ | 1.06471380 |
99 | MP0004233_abnormal_muscle_weight | 1.05410536 |
100 | MP0004145_abnormal_muscle_electrophysio | 1.04332205 |
101 | MP0005275_abnormal_skin_tensile | 1.03510348 |
102 | MP0001968_abnormal_touch/_nociception | 1.03466681 |
103 | MP0005083_abnormal_biliary_tract | 1.01920018 |
104 | MP0005365_abnormal_bile_salt | 1.01752059 |
105 | MP0004142_abnormal_muscle_tone | 1.01317623 |
106 | MP0001191_abnormal_skin_condition | 1.00209728 |
107 | MP0008877_abnormal_DNA_methylation | 0.97912084 |
108 | MP0003828_pulmonary_edema | 0.97861601 |
109 | MP0002822_catalepsy | 0.97742297 |
110 | MP0000462_abnormal_digestive_system | 0.95781696 |
111 | MP0002060_abnormal_skin_morphology | 0.95442267 |
112 | MP0002090_abnormal_vision | 0.95315782 |
113 | MP0003453_abnormal_keratinocyte_physiol | 0.94842945 |
114 | MP0005167_abnormal_blood-brain_barrier | 0.94575850 |
115 | MP0008569_lethality_at_weaning | 0.94184589 |
116 | MP0003191_abnormal_cellular_cholesterol | 0.93463468 |
117 | MP0001661_extended_life_span | 0.92408490 |
118 | MP0001216_abnormal_epidermal_layer | 0.92002575 |
119 | MP0008932_abnormal_embryonic_tissue | 0.91106150 |
120 | MP0002009_preneoplasia | 0.90825122 |
121 | MP0002184_abnormal_innervation | 0.90730732 |
122 | MP0003890_abnormal_embryonic-extraembry | 0.90630694 |
123 | MP0006276_abnormal_autonomic_nervous | 0.90584584 |
124 | MP0005384_cellular_phenotype | 0.90399962 |
125 | MP0002229_neurodegeneration | 0.88733211 |
126 | MP0002877_abnormal_melanocyte_morpholog | 0.88500481 |
127 | MP0008007_abnormal_cellular_replicative | 0.88329591 |
128 | MP0005621_abnormal_cell_physiology | 0.87666856 |
129 | MP0005187_abnormal_penis_morphology | 0.86739808 |
130 | MP0002896_abnormal_bone_mineralization | 0.86183777 |
131 | MP0003950_abnormal_plasma_membrane | 0.85804369 |
132 | MP0000003_abnormal_adipose_tissue | 0.84322695 |
133 | MP0005379_endocrine/exocrine_gland_phen | 0.83535981 |
134 | MP0001177_atelectasis | 0.83358391 |
135 | MP0006035_abnormal_mitochondrial_morpho | 0.82701310 |
136 | MP0004957_abnormal_blastocyst_morpholog | 0.82624988 |
137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82547567 |
138 | MP0009703_decreased_birth_body | 0.82237143 |
139 | MP0002735_abnormal_chemical_nociception | 0.82000233 |
140 | MP0002972_abnormal_cardiac_muscle | 0.80689786 |
141 | MP0002882_abnormal_neuron_morphology | 0.80478648 |
142 | MP0004811_abnormal_neuron_physiology | 0.79929962 |
143 | MP0001905_abnormal_dopamine_level | 0.79649437 |
144 | MP0000579_abnormal_nail_morphology | 0.79023223 |
145 | MP0002133_abnormal_respiratory_system | 0.78862715 |
146 | MP0005388_respiratory_system_phenotype | 0.78862715 |
147 | MP0000537_abnormal_urethra_morphology | 0.78849014 |
148 | MP0001348_abnormal_lacrimal_gland | 0.77289579 |
149 | MP0004215_abnormal_myocardial_fiber | 0.77281720 |
150 | MP0004484_altered_response_of | 0.76958595 |
151 | MP0000647_abnormal_sebaceous_gland | 0.75676261 |
152 | MP0008438_abnormal_cutaneous_collagen | 0.73729562 |
153 | MP0005164_abnormal_response_to | 0.73619952 |
154 | MP0000465_gastrointestinal_hemorrhage | 0.71568394 |
155 | MP0005375_adipose_tissue_phenotype | 0.70449950 |
156 | MP0009672_abnormal_birth_weight | 0.69765783 |
157 | MP0005595_abnormal_vascular_smooth | 0.68999472 |
158 | MP0010368_abnormal_lymphatic_system | 0.68510147 |
159 | MP0008873_increased_physiological_sensi | 0.66498503 |
160 | MP0004036_abnormal_muscle_relaxation | 0.66344071 |
161 | MP0010386_abnormal_urinary_bladder | 0.66065008 |
162 | MP0002295_abnormal_pulmonary_circulatio | 0.65091156 |
163 | MP0001346_abnormal_lacrimal_gland | 0.64221206 |
164 | MP0001502_abnormal_circadian_rhythm | 0.63842736 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 5.01602142 |
2 | Cerebral inclusion bodies (HP:0100314) | 4.48480742 |
3 | Papillary thyroid carcinoma (HP:0002895) | 4.42237787 |
4 | Tetraparesis (HP:0002273) | 4.02555361 |
5 | Agnosia (HP:0010524) | 4.01328078 |
6 | Disinhibition (HP:0000734) | 3.76021155 |
7 | Cortical dysplasia (HP:0002539) | 3.64985996 |
8 | Insidious onset (HP:0003587) | 3.55932696 |
9 | Termporal pattern (HP:0011008) | 3.55932696 |
10 | Supranuclear gaze palsy (HP:0000605) | 3.38866516 |
11 | Spastic diplegia (HP:0001264) | 3.35813970 |
12 | Upper limb muscle weakness (HP:0003484) | 3.31806631 |
13 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.26993057 |
14 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.26993057 |
15 | Myokymia (HP:0002411) | 3.17194228 |
16 | Intention tremor (HP:0002080) | 3.06958322 |
17 | Shoulder girdle muscle weakness (HP:0003547) | 3.06890461 |
18 | Thyroid carcinoma (HP:0002890) | 3.06876606 |
19 | Action tremor (HP:0002345) | 3.02114833 |
20 | Ankle clonus (HP:0011448) | 3.00999602 |
21 | Focal motor seizures (HP:0011153) | 2.94823074 |
22 | Hyperglycinemia (HP:0002154) | 2.90733074 |
23 | Polyphagia (HP:0002591) | 2.77307845 |
24 | Pelvic girdle muscle weakness (HP:0003749) | 2.77262268 |
25 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.76111982 |
26 | Peripheral hypomyelination (HP:0007182) | 2.72681150 |
27 | Nuclear cataract (HP:0100018) | 2.72343597 |
28 | Visual hallucinations (HP:0002367) | 2.71087194 |
29 | Gout (HP:0001997) | 2.70479703 |
30 | Curly hair (HP:0002212) | 2.68324493 |
31 | Abnormal hair whorl (HP:0010721) | 2.67932751 |
32 | Dysmetria (HP:0001310) | 2.67832542 |
33 | Apathy (HP:0000741) | 2.67179893 |
34 | Inappropriate behavior (HP:0000719) | 2.65255650 |
35 | Amyotrophic lateral sclerosis (HP:0007354) | 2.64157501 |
36 | Atonic seizures (HP:0010819) | 2.63813114 |
37 | Achilles tendon contracture (HP:0001771) | 2.60155121 |
38 | Autoamputation (HP:0001218) | 2.56920346 |
39 | Abnormality of the Achilles tendon (HP:0005109) | 2.56786571 |
40 | Stenosis of the external auditory canal (HP:0000402) | 2.52396407 |
41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.51889498 |
42 | Abnormality of the anterior horn cell (HP:0006802) | 2.51213311 |
43 | Degeneration of anterior horn cells (HP:0002398) | 2.51213311 |
44 | Abnormality of the corticospinal tract (HP:0002492) | 2.47500569 |
45 | Muscle fiber splitting (HP:0003555) | 2.47317657 |
46 | Diminished motivation (HP:0000745) | 2.46968311 |
47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43870999 |
48 | Global brain atrophy (HP:0002283) | 2.42432646 |
49 | Focal seizures (HP:0007359) | 2.42395666 |
50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42235178 |
51 | Cerebral hemorrhage (HP:0001342) | 2.42194702 |
52 | Megalencephaly (HP:0001355) | 2.41984661 |
53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41702526 |
54 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41702526 |
55 | Xanthomatosis (HP:0000991) | 2.38528645 |
56 | Delusions (HP:0000746) | 2.35872821 |
57 | Medulloblastoma (HP:0002885) | 2.33071158 |
58 | Abnormal gallbladder physiology (HP:0012438) | 2.33020724 |
59 | Cholecystitis (HP:0001082) | 2.33020724 |
60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32174844 |
61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32174844 |
62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32174844 |
63 | Restlessness (HP:0000711) | 2.30869787 |
64 | Abnormality of glycine metabolism (HP:0010895) | 2.30854732 |
65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.30854732 |
66 | Dialeptic seizures (HP:0011146) | 2.30759998 |
67 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29907215 |
68 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29907215 |
69 | Aplasia involving bones of the extremities (HP:0009825) | 2.29907215 |
70 | Tetraplegia (HP:0002445) | 2.29687367 |
71 | Spastic gait (HP:0002064) | 2.28963209 |
72 | Onion bulb formation (HP:0003383) | 2.28695524 |
73 | Spastic tetraparesis (HP:0001285) | 2.27476493 |
74 | Split foot (HP:0001839) | 2.26941772 |
75 | Absence seizures (HP:0002121) | 2.22047617 |
76 | Clonus (HP:0002169) | 2.20860516 |
77 | Pheochromocytoma (HP:0002666) | 2.20688254 |
78 | Progressive inability to walk (HP:0002505) | 2.17250189 |
79 | Hyperglycinuria (HP:0003108) | 2.12676001 |
80 | Abnormal auditory evoked potentials (HP:0006958) | 2.12062942 |
81 | Vacuolated lymphocytes (HP:0001922) | 2.10793568 |
82 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.10677660 |
83 | Loss of speech (HP:0002371) | 2.10386670 |
84 | Turricephaly (HP:0000262) | 2.09891224 |
85 | Urinary urgency (HP:0000012) | 2.08653261 |
86 | Dysdiadochokinesis (HP:0002075) | 2.07825170 |
87 | Congenital primary aphakia (HP:0007707) | 2.06581034 |
88 | Gait imbalance (HP:0002141) | 2.06306004 |
89 | Akinesia (HP:0002304) | 2.04886953 |
90 | Clumsiness (HP:0002312) | 2.03556483 |
91 | Generalized tonic-clonic seizures (HP:0002069) | 2.03036005 |
92 | Neoplasm of the thyroid gland (HP:0100031) | 2.01989930 |
93 | Neuroendocrine neoplasm (HP:0100634) | 2.00684706 |
94 | Symptomatic seizures (HP:0011145) | 2.00281326 |
95 | Hematochezia (HP:0002573) | 2.00219696 |
96 | Freckling (HP:0001480) | 1.99998215 |
97 | Increased serum pyruvate (HP:0003542) | 1.99066218 |
98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98785061 |
99 | Axonal loss (HP:0003447) | 1.97947531 |
100 | Spastic paraparesis (HP:0002313) | 1.97487859 |
101 | Hyperlipoproteinemia (HP:0010980) | 1.97342819 |
102 | Thickened helices (HP:0000391) | 1.94214184 |
103 | CNS hypomyelination (HP:0003429) | 1.93282039 |
104 | Abnormality of the motor neurons (HP:0002450) | 1.92889281 |
105 | Abnormal neuron morphology (HP:0012757) | 1.92889281 |
106 | Erythroderma (HP:0001019) | 1.92787415 |
107 | Bladder carcinoma (HP:0002862) | 1.92602102 |
108 | Bladder neoplasm (HP:0009725) | 1.92602102 |
109 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.92381515 |
110 | Delayed gross motor development (HP:0002194) | 1.91644255 |
111 | Intrahepatic cholestasis (HP:0001406) | 1.90422490 |
112 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.89822290 |
113 | Palpitations (HP:0001962) | 1.88151657 |
114 | Cerebral hypomyelination (HP:0006808) | 1.88099730 |
115 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85500466 |
116 | Thick nail (HP:0001805) | 1.85498373 |
117 | Abnormality of glycolysis (HP:0004366) | 1.84870506 |
118 | Distal sensory impairment (HP:0002936) | 1.84865886 |
119 | Ventricular fibrillation (HP:0001663) | 1.84554703 |
120 | Peripheral demyelination (HP:0011096) | 1.83532615 |
121 | Premature rupture of membranes (HP:0001788) | 1.82996026 |
122 | Hand muscle atrophy (HP:0009130) | 1.82754918 |
123 | Truncal ataxia (HP:0002078) | 1.82016757 |
124 | Dysostosis multiplex (HP:0000943) | 1.81677687 |
125 | Biliary tract neoplasm (HP:0100574) | 1.81434875 |
126 | Decreased motor nerve conduction velocity (HP:0003431) | 1.80921531 |
127 | Irritability (HP:0000737) | 1.80002371 |
128 | Increased cerebral lipofuscin (HP:0011813) | 1.79990753 |
129 | Hyporeflexia of lower limbs (HP:0002600) | 1.79106217 |
130 | Atrioventricular block (HP:0001678) | 1.79081064 |
131 | Neuronal loss in central nervous system (HP:0002529) | 1.78944716 |
132 | Choroideremia (HP:0001139) | 1.78175668 |
133 | Cutaneous melanoma (HP:0012056) | 1.78129323 |
134 | Patchy hypopigmentation of hair (HP:0011365) | 1.78074940 |
135 | Anxiety (HP:0000739) | 1.77652988 |
136 | Parakeratosis (HP:0001036) | 1.76799138 |
137 | Mutism (HP:0002300) | 1.76785331 |
138 | Abnormal eating behavior (HP:0100738) | 1.76259265 |
139 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.76254549 |
140 | Medial flaring of the eyebrow (HP:0010747) | 1.76187042 |
141 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.75471445 |
142 | Progressive external ophthalmoplegia (HP:0000590) | 1.75353112 |
143 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75289749 |
144 | Synostosis involving the elbow (HP:0003938) | 1.74817945 |
145 | Humeroradial synostosis (HP:0003041) | 1.74817945 |
146 | Amyloidosis (HP:0011034) | 1.74704104 |
147 | Depression (HP:0000716) | 1.74666847 |
148 | Lower limb muscle weakness (HP:0007340) | 1.74524121 |
149 | Rapidly progressive (HP:0003678) | 1.74368762 |
150 | Scanning speech (HP:0002168) | 1.74214153 |
151 | Metaphyseal dysplasia (HP:0100255) | 1.74166833 |
152 | Paraparesis (HP:0002385) | 1.73715222 |
153 | Bronchomalacia (HP:0002780) | 1.73462900 |
154 | Difficulty running (HP:0009046) | 1.73201241 |
155 | Hip dysplasia (HP:0001385) | 1.72963019 |
156 | Exercise-induced muscle cramps (HP:0003710) | 1.72280069 |
157 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.72029754 |
158 | Gastrointestinal carcinoma (HP:0002672) | 1.72029754 |
159 | Uterine neoplasm (HP:0010784) | 1.71720734 |
160 | Hammertoe (HP:0001765) | 1.70573217 |
161 | Neoplasm of the small intestine (HP:0100833) | 1.70551383 |
162 | Gowers sign (HP:0003391) | 1.70012812 |
163 | Resting tremor (HP:0002322) | 1.67248175 |
164 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.66779941 |
165 | Generalized myoclonic seizures (HP:0002123) | 1.66073153 |
166 | Buphthalmos (HP:0000557) | 1.65465706 |
167 | Postural tremor (HP:0002174) | 1.65150990 |
168 | Rigidity (HP:0002063) | 1.64424900 |
169 | Anteriorly placed anus (HP:0001545) | 1.63911238 |
170 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.63022633 |
171 | Deep venous thrombosis (HP:0002625) | 1.62293082 |
172 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.62139826 |
173 | Hyperglycemia (HP:0003074) | 1.61992273 |
174 | Postnatal microcephaly (HP:0005484) | 1.61432484 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 3.64125631 |
2 | MAP3K9 | 3.40793824 |
3 | TRIM28 | 3.30916815 |
4 | NTRK1 | 3.07708441 |
5 | KSR2 | 2.86472141 |
6 | ERBB3 | 2.66381976 |
7 | OXSR1 | 2.57806691 |
8 | PLK2 | 2.31222524 |
9 | FGFR2 | 2.23226630 |
10 | EPHA4 | 2.17690117 |
11 | MAP3K2 | 2.15736175 |
12 | NTRK3 | 2.12004330 |
13 | EIF2AK3 | 2.10330524 |
14 | PAK6 | 2.04143105 |
15 | TSSK6 | 2.02058855 |
16 | RIPK4 | 2.01935909 |
17 | PNCK | 1.97450499 |
18 | TYRO3 | 1.94922915 |
19 | WNK4 | 1.92900361 |
20 | TNIK | 1.90747444 |
21 | SIK3 | 1.82620384 |
22 | SCYL2 | 1.79440156 |
23 | GRK7 | 1.78571531 |
24 | ARAF | 1.76989793 |
25 | BMPR2 | 1.75875097 |
26 | TESK1 | 1.75858308 |
27 | STK24 | 1.70178543 |
28 | DYRK3 | 1.65278871 |
29 | IRAK3 | 1.63362800 |
30 | SRPK1 | 1.62244006 |
31 | FRK | 1.59801138 |
32 | EPHB1 | 1.54188300 |
33 | MINK1 | 1.53139174 |
34 | KSR1 | 1.53013646 |
35 | PAK3 | 1.51108841 |
36 | STK38L | 1.49801366 |
37 | DDR2 | 1.47744630 |
38 | EIF2AK1 | 1.46707214 |
39 | BCR | 1.45947214 |
40 | PLK3 | 1.45881172 |
41 | MAP2K4 | 1.45402399 |
42 | STK16 | 1.41840735 |
43 | MET | 1.40602424 |
44 | DAPK2 | 1.39867979 |
45 | CSNK1G2 | 1.38163059 |
46 | LATS2 | 1.32811503 |
47 | PINK1 | 1.31773764 |
48 | MAPKAPK5 | 1.31457325 |
49 | TRIB3 | 1.29591877 |
50 | LMTK2 | 1.28401206 |
51 | NEK1 | 1.26909657 |
52 | LIMK1 | 1.26357299 |
53 | MARK1 | 1.25414257 |
54 | MAP2K7 | 1.22377935 |
55 | PAK4 | 1.17078428 |
56 | CDK19 | 1.16924458 |
57 | CDK5 | 1.16498628 |
58 | CAMKK2 | 1.16390733 |
59 | YES1 | 1.16386651 |
60 | STK3 | 1.16255346 |
61 | UHMK1 | 1.12829241 |
62 | MYLK | 1.11998806 |
63 | EPHA3 | 1.11892675 |
64 | GRK5 | 1.11610406 |
65 | PDPK1 | 1.08600808 |
66 | CSNK1G3 | 1.07851743 |
67 | DMPK | 1.07230714 |
68 | FGR | 1.06821063 |
69 | PRKD3 | 1.06819808 |
70 | PIM2 | 1.05574101 |
71 | CSNK1G1 | 1.04992935 |
72 | RET | 1.03946448 |
73 | FER | 1.02645454 |
74 | WNK1 | 1.00636505 |
75 | MAP3K14 | 0.97935175 |
76 | CLK1 | 0.96558009 |
77 | CAMK2B | 0.96394999 |
78 | GSK3A | 0.95581163 |
79 | MAP3K13 | 0.93544228 |
80 | CAMKK1 | 0.92137667 |
81 | PHKG2 | 0.91647694 |
82 | PHKG1 | 0.91647694 |
83 | MAPK15 | 0.91166929 |
84 | CSNK1A1L | 0.90178884 |
85 | MAP3K4 | 0.90014357 |
86 | MST4 | 0.89086010 |
87 | CAMK2G | 0.88692087 |
88 | STK11 | 0.87449834 |
89 | AKT3 | 0.87347113 |
90 | RAF1 | 0.85101509 |
91 | CAMK2D | 0.81801872 |
92 | CDK14 | 0.80594548 |
93 | PDK2 | 0.78560355 |
94 | PDK1 | 0.76786954 |
95 | MAP3K1 | 0.76598874 |
96 | PTK2 | 0.76522147 |
97 | CAMK2A | 0.76372846 |
98 | PDK4 | 0.76319060 |
99 | PDK3 | 0.76319060 |
100 | BMPR1B | 0.76262346 |
101 | ALK | 0.74322730 |
102 | ERBB4 | 0.73401309 |
103 | EGFR | 0.73233840 |
104 | TTK | 0.73155263 |
105 | MKNK1 | 0.72683977 |
106 | MAP2K1 | 0.72407849 |
107 | BCKDK | 0.72397484 |
108 | IRAK1 | 0.71478998 |
109 | ABL2 | 0.71442640 |
110 | WNK3 | 0.66229352 |
111 | PDGFRA | 0.65263895 |
112 | * PRKCE | 0.64743797 |
113 | MOS | 0.62576122 |
114 | PRKCG | 0.62470557 |
115 | ICK | 0.62384308 |
116 | NLK | 0.61690667 |
117 | TGFBR2 | 0.60304648 |
118 | PRKD1 | 0.60007817 |
119 | NEK6 | 0.59897367 |
120 | TIE1 | 0.59653954 |
121 | RPS6KA4 | 0.59240249 |
122 | MKNK2 | 0.57579119 |
123 | NTRK2 | 0.56587898 |
124 | ROCK2 | 0.55905100 |
125 | MELK | 0.55221145 |
126 | DAPK1 | 0.55142026 |
127 | BRAF | 0.54976250 |
128 | CDK15 | 0.53380664 |
129 | LATS1 | 0.51558228 |
130 | MAP3K3 | 0.51162134 |
131 | TAF1 | 0.50786223 |
132 | PIK3CA | 0.50264643 |
133 | PRKCH | 0.49580924 |
134 | EIF2AK2 | 0.48140109 |
135 | STK38 | 0.47771704 |
136 | CDK6 | 0.47651146 |
137 | MAP3K12 | 0.46255110 |
138 | MAPK10 | 0.45357386 |
139 | NEK9 | 0.45325987 |
140 | JAK1 | 0.44681513 |
141 | CDK18 | 0.44555385 |
142 | SGK223 | 0.44257115 |
143 | SGK494 | 0.44257115 |
144 | MAP2K2 | 0.44023410 |
145 | PBK | 0.43334699 |
146 | MAP3K5 | 0.43306092 |
147 | ACVR1B | 0.42373013 |
148 | PDGFRB | 0.41973218 |
149 | PKN1 | 0.41549210 |
150 | DYRK2 | 0.41487115 |
151 | CDK11A | 0.40080574 |
152 | HIPK2 | 0.39673208 |
153 | FGFR1 | 0.37665505 |
154 | DYRK1A | 0.37430529 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.79854176 |
2 | Protein export_Homo sapiens_hsa03060 | 3.45792251 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.80524517 |
4 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.46522544 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.38670167 |
6 | Legionellosis_Homo sapiens_hsa05134 | 2.17209726 |
7 | Salmonella infection_Homo sapiens_hsa05132 | 2.13801985 |
8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.07692069 |
9 | Shigellosis_Homo sapiens_hsa05131 | 2.06076718 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.93613312 |
11 | Proteasome_Homo sapiens_hsa03050 | 1.84396866 |
12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.81866682 |
13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.78016812 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65552480 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63215074 |
16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60189453 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.57987125 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57810727 |
19 | Adherens junction_Homo sapiens_hsa04520 | 1.57779459 |
20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52643494 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48976090 |
22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48474037 |
23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40657237 |
24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39769924 |
25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39684564 |
26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.37270072 |
27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.32443229 |
28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29149439 |
29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.28119491 |
30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27165018 |
31 | Salivary secretion_Homo sapiens_hsa04970 | 1.26224484 |
32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26222392 |
33 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25680374 |
34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24750620 |
35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22946702 |
36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.22473654 |
37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.21320483 |
38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17971891 |
39 | Long-term depression_Homo sapiens_hsa04730 | 1.17228145 |
40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16216588 |
41 | Pertussis_Homo sapiens_hsa05133 | 1.14147858 |
42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12235424 |
43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11742971 |
44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11721565 |
45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11254642 |
46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11188465 |
47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08986669 |
48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08903578 |
49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07481140 |
50 | Renin secretion_Homo sapiens_hsa04924 | 1.06746528 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05910112 |
52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04654509 |
53 | Insulin secretion_Homo sapiens_hsa04911 | 1.04198774 |
54 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03959548 |
55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03952638 |
56 | Prion diseases_Homo sapiens_hsa05020 | 1.03175930 |
57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02401617 |
58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.00342761 |
59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99943952 |
60 | * Phagosome_Homo sapiens_hsa04145 | 0.99906535 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99040892 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98539600 |
63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97777042 |
64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97677010 |
65 | Bile secretion_Homo sapiens_hsa04976 | 0.95095054 |
66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94242540 |
67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89763439 |
68 | Tight junction_Homo sapiens_hsa04530 | 0.88994645 |
69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88978767 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.88639238 |
71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86717986 |
72 | Gap junction_Homo sapiens_hsa04540 | 0.86600716 |
73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86553004 |
74 | Morphine addiction_Homo sapiens_hsa05032 | 0.85561396 |
75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84851454 |
76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84070899 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83513707 |
78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83065610 |
79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81234767 |
80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80051628 |
81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78720655 |
82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78208372 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77731948 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77607463 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77510190 |
86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77304334 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76580130 |
88 | Malaria_Homo sapiens_hsa05144 | 0.75190901 |
89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73930423 |
90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73553198 |
91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72472662 |
92 | * Amoebiasis_Homo sapiens_hsa05146 | 0.72051769 |
93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71856671 |
94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71819329 |
95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71408124 |
96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70915649 |
97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69808624 |
98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69092139 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68995716 |
100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67735175 |
101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66730453 |
102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66646418 |
103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66187428 |
104 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65586155 |
105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65046822 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64768961 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64050611 |
108 | * Tuberculosis_Homo sapiens_hsa05152 | 0.64009683 |
109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63021884 |
110 | Hepatitis C_Homo sapiens_hsa05160 | 0.61710823 |
111 | Taste transduction_Homo sapiens_hsa04742 | 0.61384431 |
112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60794887 |
113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60673298 |
114 | * Endocytosis_Homo sapiens_hsa04144 | 0.59704240 |
115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59113988 |
116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58069676 |
117 | Mineral absorption_Homo sapiens_hsa04978 | 0.57956415 |
118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57932317 |
119 | Glioma_Homo sapiens_hsa05214 | 0.57727905 |
120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57098278 |
121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56690690 |
122 | Axon guidance_Homo sapiens_hsa04360 | 0.56575687 |
123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55882055 |
124 | Melanogenesis_Homo sapiens_hsa04916 | 0.54394616 |
125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54328850 |
126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54161732 |
127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53907284 |
128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53077387 |
129 | Hepatitis B_Homo sapiens_hsa05161 | 0.52856383 |
130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52725848 |
131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52583360 |
132 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51652660 |
133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50304877 |
134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48892751 |
135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48025218 |
136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46609955 |
137 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46513580 |
138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46372889 |
139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45986414 |
140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45895894 |
141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45542001 |
142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45260669 |
143 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45085226 |
144 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42641563 |
145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42173404 |
146 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41670291 |
147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41526225 |
148 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41042093 |
149 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40264673 |
150 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39792510 |
151 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38675497 |
152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37507075 |
153 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36214864 |
154 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.36157804 |
155 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34943177 |
156 | Prostate cancer_Homo sapiens_hsa05215 | 0.34612000 |
157 | Influenza A_Homo sapiens_hsa05164 | 0.32656266 |
158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30674575 |